ImpeDx is developing a rapid AST platform for positive blood and other clinical samples that will have a significant impact on health care pharmacoeconomics.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free